Guillaume Cartron - Faculty of Medicine, University Hospital of Tours

基本信息

浏览量：205

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 557 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Extreme thrombocytosis with an aggressive evolution harboring a novel variant of calreticulin (CALR) in exon 3

Sarah Bonnet,Serge Carillo,Baptiste Legrand,Barbara Burroni,Thierry Lavabre-Bertrand,Guilhem Requirand,Nicolas Robert,Lea Fornero, Ahmed Al Mansoori,Jerome Moreaux,Guillaume Cartron,Ludovic Gabellier,

EUROPEAN JOURNAL OF HAEMATOLOGYno. 3 (2024): 475-478

引用0浏览0WOS引用

SUMOylation inhibitor TAK-981 (subasumstat) synergizes with 5-azacytidine in preclinical models of acute myeloid leukemia

Ludovic Gabellier,Marion De Toledo, Mehuli Chakraborty, Dana Akl,Rawan Hallal,Mays Aqrouq, Giovanni Buonocore, Clara Recasens-Zorzo,Guillaume Cartron, Abigail Delort,Marc Piechaczyk,Denis Tempe,

HAEMATOLOGICAno. 1 (2024): 98-114

引用0浏览0WOS引用

IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma

Anastasios Stathis,Maria Cristina Pirosa,Lorella Orsucci,Pierre Feugier,Monica Tani,Hervé Ghesquières,Gerardo Musuraca,Francesca Gaia Rossi,Francesco Merli,Romain Guièze,Emmanuel Gyan,Guido Gini,

Haematologica (2024)

引用0浏览0WOS引用

The arming of NK cells with Fc-engineered rituximab confers them specificity against CD20-expressing cells

Martin Villalba,Michaël Constantinides,Loïs Coënon, Alexis Fayd'Herb de Maudave, Caroline Multrier,Mauricio Campos-Mora, Carine Jacquard,Fei Gao, Pierre Martineau,Bruno Robert,Guillaume Cartron

crossref（2024）

引用0浏览0引用

Transfusion needs after CAR T-cell therapy for large B-cell lymphoma: predictive factors and outcome (a DESCAR-T study)

Samuel Vic,Jean-Baptiste Thibert,Emmanuel Bachy,Guillaume Cartron,Thomas Gastinne,Franck Morschhauser,Fabien Le Bras, Kamal Bouabdallah,Fabien Despas,Jacques-Olivier Bay,Marie-Thérèse Rubio,Mohamad Mohty,

Blood advancesno. 6 (2024): 1573-1585

引用0浏览0WOS引用

The SUMOylation inhibitor TAK-981 (Subasumstat) triggers IFN-I-dependent activation of Natural Killer cells against Acute Myeloid Leukemias

Rawan Hallal,Marion De Toledo,Denis Tempe, Sara Zemiti,Lois Coenon,Delphine Gitenay,Simon George, Sarah Bonnet,Ludovic Gabellier,Guillaume Cartron,Mireia Pelegrin,Martin Villalba,

biorxiv（2024）

引用0浏览0引用

S238: clonal architecture of relapsed or refractory angioimmunoblastic t-cell lymphoma: an ancillary study of the oracle trial, a lysa study

Romain Loyaux,Nouhoum Sako,Violaine Tran Quang,Emmanuel Bachy,Franck Morschhauser,Guillaume Cartron,Rémy Gressin,Nicolas Daguindau,Steven Le Gouill,Cyrielle Robe, Elisa Boudali,Marie‐Hélène Delfau‐Larue,

HemaSphereno. S3 (2023): e1859693-e1859693

引用0浏览0引用

‘Don’t keep me waiting’: estimating the impact on lifetime survival and QALYs of reduced vein‐to‐vein time for LBCL patients treated with CAR T in the 3L+ setting

Richard T. Maziarz, Sachin Vadgama,Marcelo C. Pasquini, Zhen Hu, Mukurdipi Ray, Helen Smith,Ash Bullement, Mark Edmondson-Jones, W. Sullivan,Guillaume Cartron

Hematological Oncologyno. S2 (2023): 541-542

引用0浏览0引用

Obinutuzumab Versus Rituximab Immunochemotherapy in Previously Untreated iNHL: Final Results From the GALLIUM Study

William Townsend,Wolfgang Hiddemann,Christian Buske,Guillaume Cartron,David Cunningham,Martin J S Dyer,John G Gribben,Elizabeth H Phillips,Martin Dreyling,John F Seymour,Andrew Grigg,Judith Trotman,

HemaSphereno. 7 (2023): e919-e919

引用0浏览0WOS引用

A fixed-duration immunochemotherapy approach in CLL: 5.5-year results from the phase 2 ICLL-07 FILO trial

Anne-Sophie Michallet,Remi Letestu,Magali Le Garff-Tavernier,Lydia Campos,Michel Ticchioni,Marie-Sarah Dilhuydy,Stephane Morisset,Valerie Rouille,Beatrice Mahe,Kamel Laribi,Bruno Villemagne,Emmanuelle Ferrant,

Blood advancesno. 15 (2023): 3936-3945

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn